GlassScriptPhysician profile
Yuri Gelfand
NPI 1932495413
$2,888.93
in general payments reported to CMS, 2019-2025
18 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $239 · 2021: $538 · 2022: $538 · 2023: $585 · 2024: $195 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $914.38 | 2019-2025 | |
| Glaxosmithkline, LLC. | $363.42 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $341.65 | 2019-2024 | Dupixent |
| Paratek Pharmaceuticals, INC. | $288.81 | 2021-2022 | |
| Inspire Medical Systems, INC. | $195.40 | 2023-2025 | Inspire |
| Genzyme Corporation | $144.37 | 2019-2023 | |
| Stryker Corporation | $138.65 | 2019-2025 | Scopis Ent, Audion Et Dilation System |
| Alk-Abello, INC | $120.40 | 2019-2023 | Grastek, Odactra |
| Aerin Medical INC. | $100.70 | 2021-2025 | |
| Acera Surgical, INC. | $52.06 | 2024 | Restrata Wound Matrix |
| Medtronic, INC. | $49.19 | 2023 | Propel |
| Olympus America INC. | $46.44 | 2021-2023 | |
| Cochlear Americas | $36.94 | 2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Acclarent, INC | $28.01 | 2020 | |
| Arbor Pharmaceuticals, INC. | $25.55 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.38 | 2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $15.10 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuri Gelfand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.